Stock listing
NASDAQ:CUE Cue Biopharma, Inc. Stock
Home listing (NASDAQ) of Cue Biopharma, Inc.
Follow Cue Biopharma, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:CUE
$20.87 USD -0.58 (-2.7%)
Close on Oct 30, 2026
- Day range
- $19.85 – $21.17 USDOct 30, 2026
- Volume
- 60,772 sharesOct 30, 2026
- Market cap
- $151.6M USDAt the close on Oct 30, 2026 · price × 7.26M shares outstanding
- 52-week range
- $4.97 – $45.50 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $7.26M USDMedian day 176,136 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:CUE · Home | $20.87 USD | -0.58 (-2.7%) | 60,772 | $20.66 | $21.17 | $19.85 | $21.45 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · NASDAQ:CUE · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $20.87 | -0.58 | -2.7% | $20.66 | $21.17 | $19.85 | 60,772 | |
| $21.45 | +0.29 | +1.4% | $20.97 | $22.49 | $20.74 | 94,686 | |
| $21.16 | +2.84 | +15.5% | $18.46 | $21.79 | $18.44 | 140,004 | |
| $18.32 | -0.13 | -0.7% | $18.58 | $18.82 | $17.74 | 114,925 | |
| $18.45 | -0.21 | -1.1% | $18.48 | $18.85 | $17.89 | 181,713 | |
| $18.66 | -0.23 | -1.2% | $18.88 | $19.35 | $18.04 | 79,365 | |
| $18.89 | -0.06 | -0.3% | $18.57 | $19.48 | $18.29 | 54,610 | |
| $18.95 | +1.91 | +11.2% | $17.28 | $19.54 | $17.28 | 112,325 | |
| $17.04 | +0.96 | +6.0% | $15.98 | $17.93 | $15.93 | 169,199 | |
| $16.08 | -0.63 | -3.8% | $17.05 | $17.63 | $16.06 | 133,155 | |
| $16.71 | -1.96 | -10.5% | $18.57 | $18.87 | $16.54 | 106,567 | |
| $18.67 | +0.07 | +0.4% | $18.53 | $18.98 | $17.25 | 229,460 | |
| $18.60 | -0.97 | -5.0% | $20.01 | $20.79 | $18.09 | 245,074 | |
| $19.57 | -5.04 | -20.5% | $24.40 | $25.42 | $19.50 | 301,826 | |
| $24.61 | -3.05 | -11.0% | $27.44 | $29.00 | $24.48 | 179,427 | |
| $27.66 | +5.33 | +23.9% | $22.21 | $29.00 | $22.10 | 394,674 | |
| $22.33 | -0.18 | -0.8% | $22.38 | $22.74 | $21.60 | 109,897 | |
| $22.51 | -0.63 | -2.7% | $22.92 | $23.10 | $22.27 | 133,169 | |
| $23.14 | -1.22 | -5.0% | $24.22 | $24.89 | $22.92 | 174,848 | |
| $24.36 | -1.21 | -4.7% | $25.60 | $25.94 | $22.21 | 272,651 | |
| $25.57 | +0.32 | +1.3% | $25.60 | $25.92 | $24.67 | 157,036 | |
| $25.25 | -0.62 | -2.4% | $26.00 | $26.03 | $24.60 | 183,432 | |
| $25.87 | +0.36 | +1.4% | $25.89 | $27.43 | $24.88 | 228,119 | |
| $25.51 | -1.94 | -7.1% | $28.15 | $28.15 | $24.13 | 283,903 | |
| $27.45 | -3.96 | -12.6% | $30.86 | $32.07 | $27.01 | 237,825 | |
| $31.41 | -1.44 | -4.4% | $33.12 | $33.40 | $30.75 | 232,443 | |
| $32.85 | +1.14 | +3.6% | $31.15 | $33.64 | $30.44 | 330,395 | |
| $31.71 | +0.81 | +2.6% | $29.91 | $35.23 | $29.86 | 696,484 | |
| $30.90 | +2.63 | +9.3% | $28.61 | $32.39 | $25.49 | 1,205,815 | |
| $28.27 | -8.78 | -23.7% | $38.50 | $41.50 | $23.80 | 3,540,709 | |
| $37.05 | -0.79 | -2.1% | $39.35 | $41.00 | $35.54 | 381,952 | |
| $37.84 | +3.67 | +10.7% | $34.75 | $38.07 | $34.20 | 195,083 | |
| $34.17 | +2.53 | +8.0% | $31.27 | $36.47 | $30.33 | 277,389 | |
| $31.64 | +1.09 | +3.6% | $30.65 | $32.00 | $29.26 | 127,172 | |
| $30.55 | +1.81 | +6.3% | $28.24 | $31.10 | $28.24 | 136,595 | |
| $28.74 | +0.74 | +2.6% | $28.38 | $28.89 | $27.50 | 122,768 | |
| $28.00 | -2.50 | -8.2% | $30.20 | $30.91 | $27.50 | 143,189 | |
| $30.50 | +0.50 | +1.7% | $30.00 | $32.13 | $30.00 | 174,151 | |
| $30.00 | +2.56 | +9.3% | $27.39 | $30.24 | $25.62 | 260,041 | |
| $27.44 | -0.23 | -0.8% | $27.55 | $27.95 | $27.03 | 50,416 | |
| $27.67 | +0.71 | +2.6% | $26.60 | $28.09 | $26.60 | 65,684 | |
| $26.96 | -1.48 | -5.2% | $28.32 | $28.93 | $25.04 | 127,873 | |
| $28.44 | +2.92 | +11.4% | $25.29 | $29.28 | $25.01 | 177,424 | |
| $25.52 | -2.36 | -8.5% | $27.48 | $28.97 | $25.08 | 101,119 | |
| $27.88 | -0.28 | -1.0% | $28.64 | $29.75 | $26.85 | 102,262 | |
| $28.16 | -0.69 | -2.4% | $28.85 | $29.20 | $26.38 | 225,518 | |
| $28.85 | +2.09 | +7.8% | $26.63 | $29.33 | $26.26 | 205,087 | |
| $26.76 | +3.58 | +15.4% | $23.69 | $28.29 | $23.41 | 170,471 | |
| $23.18 | -0.80 | -3.3% | $23.97 | $24.19 | $22.56 | 136,572 | |
| $23.98 | -0.63 | -2.6% | $25.55 | $26.00 | $23.24 | 177,749 | |
| $24.61 | -1.67 | -6.4% | $26.44 | $28.11 | $24.40 | 158,053 | |
| $26.28 | +0.58 | +2.3% | $26.46 | $27.20 | $25.17 | 166,437 | |
| $25.70 | -1.94 | -7.0% | $27.39 | $27.95 | $24.31 | 270,689 | |
| $27.64 | -6.56 | -19.2% | $31.15 | $34.19 | $27.38 | 305,253 | |
| $34.20 | +3.12 | +10.0% | $31.89 | $34.61 | $31.16 | 157,322 | |
| $31.08 | +0.66 | +2.2% | $29.40 | $32.42 | $26.70 | 259,223 | |
| $30.42 | +2.18 | +7.7% | $28.87 | $31.00 | $26.50 | 180,736 | |
| $28.24 | +2.14 | +8.2% | $26.10 | $30.33 | $24.94 | 454,620 | |
| $26.10 | -1.02 | -3.8% | $27.39 | $27.68 | $24.80 | 316,053 | |
| $27.12 | +0.11 | +0.4% | $27.42 | $27.60 | $26.87 | 57,406 | |
| $27.01 | +0.36 | +1.4% | $26.69 | $28.46 | $26.54 | 151,065 | |
| $26.65 | +0.05 | +0.2% | $26.66 | $27.98 | $26.31 | 128,790 | |
| $26.60 | -0.27 | -1.0% | $26.92 | $27.72 | $26.03 | 187,717 | |
| $26.87 | +0.03 | +0.1% | $27.00 | $28.09 | $26.25 | 141,263 | |
| $26.84 | -3.56 | -11.7% | $29.85 | $29.85 | $25.26 | 474,917 | |
| $30.40 | +2.39 | +8.5% | $27.59 | $31.85 | $27.15 | 267,393 |
- Ticker
- NASDAQ:CUE
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Sep 20, 2026
Cue Biopharma Announces Positive Topline Results from CUE-221 Phase 2 Study in Chronic Spontaneous Urticaria
Latest deck · September 2026
Technical Presentation (September 2026)
Technical · 23 slides
Calls
Replays
Cue Biopharma (NASDAQ:CUE) Q1 2025 Earnings Call
Thu, May 15, 2025 · 11:00 AM ET
Watch TranscriptCue Biopharma (NASDAQ:CUE) Q2 2024 Earnings Call
Mon, Aug 19, 2024 · 4:30 PM ET
Watch TranscriptCue Biopharma (NASDAQ:CUE) Q4 2023 Earnings Call
Mon, Apr 08, 2024 · 4:30 PM ET
Watch Transcript
Latest news
Cue Biopharma Announces Positive Topline Results from CUE-221 Phase 2 Study in Chronic Spontaneous Urticaria
Sep 20, 2026
Closed $28.27 (-23.7%) on Sep 21, 2026
Cue Biopharma Announces Appointment of James M. Ahlers as Chief Financial Officer and CUE-221 Investigational New Drug Submission
Aug 3, 2026
Closed $26.87 (+0.1%) on Aug 3, 2026
Cue Biopharma Appoints Dominic Borie, M.D., Ph.D., as Chief Medical Officer and Head of Research & Development
Jul 13, 2026
Closed $30.92 (-15.9%) on Jul 13, 2026
Cue Biopharma Announces $50.0 Million Private Placement
Jul 9, 2026
Closed $36.78 (+0.7%) on Jul 10, 2026
Cue Biopharma Announces Board Transition and Addition of New Directors with Continued Company Evolution
Jun 2, 2026
Closed $26.91 (-6.0%) on Jun 3, 2026
Cue Biopharma to Present at the 2026 Jefferies Global Healthcare Conference
May 21, 2026
Closed $21.47 (+6.8%) on May 22, 2026
Cue Biopharma Reports First Quarter 2026 Financial Results and Recent Strategic Developments
May 14, 2026
Closed $23.01 (-9.2%) on May 15, 2026
Cue Biopharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 7, 2026
Closed $35.00 (-2.0%) on May 8, 2026
Cue Biopharma Announces $30 Million Private Placement
Apr 30, 2026
Closed $30.42 (+106.4%) on May 1, 2026
Financings
Private placement of common stock and pre-funded warrants
Jul 10, 2026
Announced: about US$50M · US$33.21 a share
Buyers: Cormorant Asset Management; Columbia Threadneedle Investments
Use of proceeds: Further fund clinical development and general corporate purposes
Decks
Technical Presentation (September 2026)
Technical · 23 slides · September 2026
Investor Presentation (July 2026)
Investor deck · 22 slides · July 2026
Investor Presentation (June 2026)
Investor deck · 22 slides · Jun 3, 2026
Investor Presentation (June 2026)
Investor deck · 11 slides · Jun 1, 2026
Cue Biopharma, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 23 in the last 12 months · 111 in all · newest Sep 20, 2026 · oldest 2019
- Calls
- 8 calls with a replay · 8 with a transcript · latest May 15, 2025
- Decks
- 33 decks · latest September 2026
Where Cue Biopharma, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:CUE · Home listing · This page | NASDAQ | United States | USD |
| BOATS:CUE | BOATS | United States | USD |
| gettex:1UC0 | gettex | Germany | EUR |
| LS Exchange:A426PN | LS Exchange | Germany | EUR |
| Lang & Schwarz:A426PN | Lang & Schwarz | Germany | EUR |
| Tradegate:1UC0 | Tradegate | Germany | EUR |
| Frankfurt:1UC0 | Frankfurt | Germany | EUR |
| Dusseldorf:1UC0 | Dusseldorf | Germany | EUR |
| Munich:1UC0 | Munich | Germany | EUR |
| Stuttgart:1UC0 | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about Cue Biopharma, Inc.